Intrinsic Value of S&P & Nasdaq Contact Us

Silence Therapeutics plc SLN NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • GB • USD

SharesGrow Score
56/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$57.00
+683%

Silence Therapeutics plc (SLN) has 12 identified peers for comparison in the Healthcare sector. Peers include APLT, CCCC, CDTX, CERE, CGEM, CNTA and others.

SLN has a market capitalization of $343.86M, compared to an average peer market cap of $2.14B. SLN is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message